Status:
COMPLETED
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Ductal Carcinoma in Situ
Eligibility:
FEMALE
50-79 years
Phase:
NA
Brief Summary
The purpose of this research study is to evaluate a decision support tool for patients diagnosed with ductal carcinoma in situ (DCIS).
Detailed Description
Today, guideline concordant care options for patients diagnosed with ductal carcinoma in situ (DCIS) are lumpectomy (with or without radiation treatment) and mastectomy, with optional endocrine therap...
Eligibility Criteria
Inclusion
- Sex: Female
- Age: 50-79 years
- Has had a negative mammographic screen in the past 12 months
Exclusion
- Personal history of breast cancer
Key Trial Info
Start Date :
October 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
322 Patients enrolled
Trial Details
Trial ID
NCT03775213
Start Date
October 12 2021
End Date
January 31 2022
Last Update
January 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Mammography Clinic
Durham, North Carolina, United States, 27710